VSee Health (VSEE)
NASDAQ:VSEE
Want to see VSEE full AI Analyst Report?
Top Page
VSee Health
(NASDAQ:VSEE)
Select Model
Select Model
Rating:40Underperform
Price Target:
$0.12
▼(-69.47% Downside)
Action:Downgraded
Date:06/16/26
The score is driven primarily by weak financial performance (large operating/net losses and ongoing cash burn) and bearish technicals (price below all major moving averages with negative MACD). Valuation provides limited offset because earnings are negative and no dividend yield is available.
Positive Factors
HIPAA-compliant telehealth platform
VSee’s core product is a HIPAA-compliant telehealth and clinical workflow platform, a durable asset in healthcare. Enterprise-grade compliance and workflow integration support recurring contracts, stickier customer relationships, and predictable subscription and services revenue over multiple quarters.
Negative Factors
Material operating cash burn
Sustained negative operating cash flow of roughly -$5.5M TTM is a structural weakness: it requires continual external funding, limits ability to self-fund growth, increases dilution risk, and constrains long-term investments in R&D and sales needed to scale the platform.
Read all positive and negative factors
Positive Factors
Negative Factors
HIPAA-compliant telehealth platform
VSee’s core product is a HIPAA-compliant telehealth and clinical workflow platform, a durable asset in healthcare. Enterprise-grade compliance and workflow integration support recurring contracts, stickier customer relationships, and predictable subscription and services revenue over multiple quarters.
Read all positive factors
VSee Health (VSEE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.62M
Dividend YieldN/A
Average Volume (3M)1.90M
Price to Earnings (P/E)―
Beta (1Y)0.56
Revenue Growth18.05%
EPS Growth86.68%
CountryUS
Employees2
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.54
Shares Outstanding48,600,000
10 Day Avg. Volume5,577,105
30 Day Avg. Volume1,899,699
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.52
P/FCF Ratio-2.17
Enterprise Value/Market Cap0.50
Enterprise Value/Revenue0.19
Enterprise Value/Gross Profit0.42
Enterprise Value/Ebitda-0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.24
Revenue Forecast (FY)$21.60M
VSee Health Business Overview & Revenue Model
Company Description
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care envi...
How the Company Makes Money
VSee Health primarily makes money by providing telehealth software and related services to healthcare organizations on a contractual basis. Key revenue streams include: (1) Software/platform revenue: fees for access to its telehealth platform (typ...
VSee Health Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
36
Negative
Cash Flow
22
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.46M | 14.62M | 10.42M | 5.77M | 6.38M | 7.34M |
| Gross Profit | 6.69M | 7.36M | 7.18M | 3.83M | 4.84M | 5.92M |
| EBITDA | -8.67M | -9.18M | -3.36M | -1.79M | 0.00 | 386.34K |
| Net Income | -13.35M | -14.71M | -57.70M | -3.76M | -836.21K | 475.90K |
Balance Sheet | ||||||
| Total Assets | 19.02M | 22.41M | 19.99M | 805.79K | 2.61M | 117.94M |
| Cash, Cash Equivalents and Short-Term Investments | 1.35M | 5.27M | 326.12K | 118.73K | 230.66K | 760.01K |
| Total Debt | 2.14M | 2.44M | 9.55M | 543.00K | 517.13K | 0.00 |
| Total Liabilities | 12.70M | 16.96M | 20.01M | 5.11M | 2.61M | 4.55M |
| Stockholders Equity | 6.32M | 5.45M | -18.49K | -3.97M | 360.72K | 113.39M |
Cash Flow | ||||||
| Free Cash Flow | -5.50M | -3.48M | -5.84M | -636.93K | -1.45M | -600.11K |
| Operating Cash Flow | -5.46M | -3.45M | -5.79M | -632.60K | -1.45M | -600.11K |
| Investing Cash Flow | -144.81K | -29.93K | -26.14K | -4.33K | 110.12M | -116.73M |
| Financing Cash Flow | 6.54M | 8.42M | 6.02M | 525.00K | -109.32M | 118.09M |
VSee Health Technical Analysis
Negative
0.38
Price Trends
0.18
Negative
0.24
Negative
0.43
Negative
Market Momentum
-0.02
Positive
29.08
Positive
14.22
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VSEE, the sentiment is Negative. The current price of 0.38 is above the 20-day moving average (MA) of 0.16, above the 50-day MA of 0.18, and below the 200-day MA of 0.43, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 29.08 is Positive, neither overbought nor oversold. The STOCH value of 14.22 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VSEE.
VSee Health Risk Analysis
VSee Health disclosed 61 risk factors in its most recent earnings report. VSee Health reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
VSee Health Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | $140.85M | -1.59 | -35.14% | ― | -9.29% | 46.89% | |
54 Neutral | $1.46B | -8.45 | -12.37% | ― | -1.50% | 83.75% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
40 Underperform | $5.62M | -0.41 | 336.68% | ― | 18.05% | 86.68% | |
| ― | $2.07M | -0.01 | -8.26% | ― | -28.30% | -86.74% |
* Healthcare Sector Average
VSEE
VSee Health
0.12
-0.98
-89.45%
TDOC
Teladoc
8.07
1.17
16.96%
ZCMD
Zhongchao
0.65
-363.91
-99.82%
AMWL
American Well
8.43
1.68
24.89%
ONMD
OneMedNet
0.56
0.20
55.28%
EUDA
EUDA Health Holdings
15.80
-58.60
-78.76%
VSee Health Corporate Events
Private Placements and FinancingRegulatory Filings and Compliance
VSee Health Establishes Standby Equity Financing Agreement
Neutral
Jun 11, 2026
On June 2, 2026, VSee Health, Inc. entered into a Standby Equity Purchase Agreement with YA II PN, LTD., giving the company the right, subject to conditions including an effective resale registration statement, to sell up to $10 million of its com...
Private Placements and Financing
VSee Health Secures New Private Debt Financing Agreement
Neutral
Jun 11, 2026
On June 8, 2026, VSee Health, Inc. entered into a securities purchase agreement with an institutional investor and issued an 8% original issue discount secured promissory note with an aggregate principal amount of $271,739.13, bearing 18% annual i...
Business Operations and StrategyExecutive/Board ChangesM&A Transactions
VSee Health divests VSee Lab and reshapes leadership
Neutral
Jun 5, 2026
On May 31, 2026, VSee Health, Inc. entered into a stock purchase agreement to sell all of the equity of its wholly owned subsidiary VSee Lab, Inc. to Milton Chen, then co-CEO, chairman and CEO of VSee Lab. In exchange, Chen assumed responsibility ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.